The PROSPER study (PROspective study of pravastatin in the elderly at risk);L'étude clinique du mois. L'étude prosper (PROspective study of pravastatin in the elderly at risk)

Revue Medicale de Liege

Volumn 57, Issue 12, 2002, Pages 809-813

  Kulbertus, H ^a   Scheen, A J ^a  

^a NONE

Author keywords

Cancer; Cholesterol lowering agents; Cognitive functions; Coronary heart disease; Pravastatin; Statins; Stroke

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN;

AGED; ARTICLE; CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; COGNITION; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; RISK FACTOR; STROKE;

EID: 0036969474     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Scandinavian Simvastatin Survival Study Group. - Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet, 1994, 344, 1383-1389.
2. Sherpherd J, Cobbe SM, Ford I, et al. - Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Eng J Med, 1995, 333, 1301-1307.
3. Sacks FM, Pfeffer MA, Moye IA, et al. - The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N EngI J Med, 1996, 335, 1001-1009.
4. Downs JR, Clearfield M, Weis S, et al. - Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA, 1998, 279, 1615-1622.
5. The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. - Prevention of cardiovascular events and death witn pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Eng J Med, 1998, 339, 1349-1357.
6. Heart Protection Study Collaborative Group. - MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high risk individuals: a randomised, placebo-controlled trial. Lancet, 2002, 360, 7-22.
7. Kulbertus H, Scheen AJ. - L'étude clinique du mois. La MRC/BHF Heart Protection Study. Rev Med Liège, 2002, 57, 613-616.
8. Scheen AJ. - Le risque cardio-vasculaire lié à l'hypercholestérolémie: d'un continuum à la notion de normalité, de seuil d'intervention et d'objectif thérapeutique. Rev Med Liège, 1999, 54, 17-21.
9. Shipley MJ, Pocock SJ, Marmot HG. - Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18 year follow-up of the Whitehall Study. BMJ, 1991, 303, 89-92.
10. Weverlin-Rijnsburger, Blauw GJ, Lagaay AM, et al. - Total cholesterol and risk of mortality in the oldest old. Lancet, 1997, 350, 1119-1123.
11. Prospective studies collaboration. - Cholesterol, diastolic blood pressure and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet, 1995, 346, 1647-1631.
12. Schatz IJ, Masaki K, Yano K et al. - Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet, 2001, 358, 351-355.
13. Shepherd J, Blauw GJ, Murphy MB et al. - on behalf of the PROSPER study group. - Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet, 2002, 360, 1623-1630.
14. Collins R, Armitage J. - High-risk elderly patients PROSPER from cholesterol-lowering therapy. Commentary. Lancet, 2002, 360, 1618-1619.
15. Scheen AJ. - La mesure de l'efficacité thérapeutique, étape essentielle dans la médecine factuelle. Rev Med Liège, 2000, 55, 206-210.
16. Byington RP, Davis BR, Plehn JF, et al. - Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project. Circulation, 2001, 103, 387-392.
17. Bjerre LM, LeLorier J. - Do statins cause cancer? A meta-analysis of large randomized clinical trials. Am J Med, 2001, 110, 716-723.
18. Cholesterol Treatment Trialists' (CTT) Collaboration. - Protocol for a prospective collaborative review of all current and planned randomized trials of cholesterol treatment regimens. Am J Cardiol, 1995, 75, 1130-1134.